Affiliation:
1. Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology
2. Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Center for Theoretical Problems of Physico-Chemical Pharmacology of RAS
3. Center for Theoretical Problems of Physico-Chemical Pharmacology of RAS
Abstract
Rosacea is a chronic inflammatory disease that affects the facial skin. This pathology is characterized by hyperaemia, erythema, telangiectasia and other manifestations. It is also accompanied by a group of unpleasant symptoms, such as burning sensations, itching, and skin tightness. The pathogenesis of the disease has not been sufficiently studied. But it is generally accepted that it is based on abnormalities in the immune system. In addition, excessive Demodex colonization and exposure to ultraviolet radiation may play a role in the development of rosacea. The incidence rate of rosacea worldwide reaches 5%. It is emphasized that some ethnicities face a greater risk of this disease than others. It is a very difficult task to treat rosacea for a specialist. The therapeutic approach differs in different forms of the disease. There is a wide range of treatments available for papulopustular rosacea, including systemic and topical medications and even physiotherapy. However, the therapy of erythematous rosacea mainly centres around the use of dermatocosmetic care. For patients with rosacea, it is important to choose products that, first of all, can effectively reduce skin redness and discomfort and will be well tolerated. A dermo-cosmetic composition has to have an anti-inflammatory effect and the ability to repair damaged skin. This article presents our own experience of using such drug in the monotherapy of erythematous rosacea and in the complex treatment of papulopustular disease. A significant effect had been achieved at 3–4 weeks of complex therapy in patients with papulopustular rosacea. We present a clinical case report of a 46-year-old patient N. as an example of the effectiveness of therapy.
Reference26 articles.
1. Wang Y, Zhang H, Fang R, Tang K, Sun Q. The top 100 most cited articles in Rosacea: a bibliometric analysis. J Eur Acad Dermatol Venereol. 2020;34(10):2177–2182. https://doi.org/10.1111/jdv.16305.
2. Tan J, Almeida LM, Bewley A, Cribier B, Dlova NC, Gallo R et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431–438. https://doi.org/10.1111/bjd.15122.
3. Dursun R, Daye M, Durmaz K. Acne and rosacea: what’s new for treatment? Dermatol Ther. 2019;32(5):e13020. https://doi.org/10.1111/dth.13020.
4. Trave I, Merlo G, Cozzani E, Parodi A. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites. Dermatol Ther. 2019;32(6):e13093. https://doi.org/10.1111/dth.13093.
5. Johnson SM, Berg A, Barr C. Managing Rosacea in the clinic: from pathophysiology to treatment – a review of the literature. J Clin Aesth Dermatol. 2020;13(4 Suppl):S17–S22. Available at: https://pubmed.ncbi.nlm.nih.gov/32802248.